PharmaNews.eu - Dynamic European Pharmaceutical News Engine

PharmaNews.eu, an advanced web based news project targeting the European pharmaceutical domain, has been launched. The project was developed to directly connect, promote and disseminate the European Industry and Research pharmaceutical achievements with additional focus on the European Commission (EC) and European Medicines Agency (EMEA) news.

Many pharmaceutical companies and research organizations are experiencing continual gaps in disseminating their news. Ruslan David, owner of the PharmaNews.eu, reported: "News dissemination is a practical necessity for many existing pharmaceutical businesses and research organisations. On other side, pharmaceutical domain is requiring up-to-date and accurate information."

He added, "PharmaNews.eu is an ambitious project focused on the European pharmaceutical industry, research and EC/ EMEA achievements. It has been designed to serve as an advanced source for the European pharmaceutical news, and it will be continuously open for our readers’ contributions, comments and suggestions - a real Pharma (Web) 2.0 approach."

At this stage, PharmaNews.eu project contains Industry News from a (growing) group of the leading pharmaceutical companies, Research and Development News articles, Conferences and Events News, EMEA News, and EC Pharmaceuticals News.

All interested Internet users are invited to explore the PharmaNews.eu project where you are very welcome to register free of charge for regular updates and news alerts.

For further information, please visit:
http://www.pharmanews.eu

Most Popular Now

Johnson & Johnson announces advance purchase a…

Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ) (the Company), has entered into an agreement with the African Vacci...

Pfizer and BioNTech confirm high efficacy and no s…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced updated topline results from analysis of 927 confirmed symptomatic cases of COVID-19 observed in their pi...

Pfizer-BioNTech announce positive topline results …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that, in a Phase 3 trial in adolescents 12 to 15 years of age with or without prior evidence of SAR...

GSK to support manufacture of Novavax' COVID-19 va…

GSK has reached an agreement in principle with Novavax and the UK Government Vaccines Taskforce to support manufacturing of up to 60 million doses of Novavax' COVID-19 va...

Valneva reports positive Phase 1/2 data for its in…

Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical n...

Clinical trial completion rates decline during COV…

Social distancing and lockdowns may have reduced the spread of COVID-19, but researchers from Penn State College of Medicine also report those actions may have affected c...

BioNTech provides update on vaccine production sta…

BioNTech SE today announced that the European Medicines Agency (EMA) approved the manufacturing of the COVID-19 vaccine drug product at the facility in Marburg. As part o...

COVID-19 convalescent plasma with greater antibody…

Convalescent plasma, the use of survivors' antibodies transfused into sick COVID-19 patients is safe and significantly improves clinical outcomes when using high levels o...

Pfizer and BioNTech request regulatory agencies ex…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today requested amendments to the U.S. Emergency Use Authorization (EUA) of the Pfizer-BioNTech vaccine (BNT162b2) ...

COVID-19 causes 'unexpected' cellular response in …

New insights into the immune response to SARS-CoV-2 infections could bring better treatments for COVID-19 cases. An international team of researchers unexpectedly foun...

Study identifies possible COVID-19 drugs - includi…

A team led by scientists in the Perelman School of Medicine at the University of Pennsylvania has identified nine potential new COVID-19 treatments, including three that ...

Undetected coronavirus variant was in at least 15 …

A highly contagious SARS-CoV-2 variant was unknowingly spreading for months in the United States by October 2020, according to a new study from researchers with The Unive...